Am Heart J

1. GRIFFITHS RI, Cavalcante R, McGovern AM, Bhave A, et al
   Cost to Medicare of Acute Kidney Injury in Percutaneous Coronary Intervention.
   Am Heart J. 2023 Apr 2:S0002-8703(23)00075-3. doi: 10.1016/j.ahj.2023.
   

   >> Share

   
   

   
   Am J Cardiol

2. LIN C, Loke WH, Ng BH, Chin YH, et al
   Mortality, Cardiovascular, and Medication Outcomes in Patients With Myocardial Infarction and Underweight in a Meta-Analysis of 6.3 Million Patients.
   Am J Cardiol. 2023;196:1-10.
   

   >> Share

   
   
3. LING W, Jiang Z, Liu K, Zhang H, et al
   Effect of Vigileo/FloTrac System-Guided Aggressive Hydration in Acute Myocardial Infarction Patients to Prevent Contrast-Induced Nephropathy After Urgent Percutaneous Coronary Intervention.
   Am J Cardiol. 2023;195:77-82.
   

   >> Share

   
   
4. BANSAL A, Belford PM, Truesdell AG, Sinha SS, et al
   Meta-Analysis on Left Ventricular Unloading With Impella in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation.
   Am J Cardiol. 2023;193:52-54.
   

   >> Share

   
   
5. KAKAR H, Groenland FTW, Elscot JJ, Rinaldi R, et al
   Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Non-ST-Elevation Coronary Syndromes and Multivessel Disease: A Systematic Review and Meta-Analysis.
   Am J Cardiol. 2023;195:70-76.
   

   >> Share

   
   
6. TOBE A, Sawano M, Kohsaka S, Ishii H, et al
   Ischemic and Bleeding Outcomes in Patients Who Underwent Percutaneous Coronary Intervention With Chronic Kidney Disease or Dialysis (from a Japanese Nationwide Registry).
   Am J Cardiol. 2023;195:37-44.
   

   >> Share

   
   

   
   Am J Med

7. YEOH A, Cheung R, Ahmed A, Chitnis AS, et al
   Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease.
   Am J Med. 2023 Mar 29:S0002-9343(23)00206-1. doi: 10.1016/j.amjmed.2023.
   

   >> Share

   
   

   
   Angiology

8. VERDOIA M, Zilio F, Viola O, Brancati MF, et al
   Long-Term Outcomes With Drug-Eluting Balloon for the Treatment of In-Stent Restenosis and De Novo Lesions: The Novara-Biella-Trento (NOBITRE) Registry.
   Angiology. 2023;74:488-495.
   

   >> Share

   
   
9. ALGUL E, Ozbeyaz NB, Sahan HF, Aydinyilmaz F, et al
   Stress Hyperglycemia Ratio Is Associated With High Thrombus Burden in Patients With Acute Coronary Syndrome.
   Angiology. 2023 Apr 2:33197231167054. doi: 10.1177/00033197231167054.
   

   >> Share

   
   

   
   Ann Clin Biochem

10. COBBAERT CM
    Implementing cardiovascular precision diagnostics: laboratory specialists as catalysts?
    Ann Clin Biochem. 2023 Apr 5:45632231166855. doi: 10.1177/00045632231166855.
    

    >> Share

    
    

    
    Arterioscler Thromb Vasc Biol

11. LEE B, Lee SJ, Kim BK, Lee YJ, et al
    Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial.
    Arterioscler Thromb Vasc Biol. 2023 Apr 6. doi: 10.1161/ATVBAHA.122.318725.
    

    >> Share

    
    

    
    Cardiovasc Res

12. SEMENZA GL
    Hypoxia-inducible factors: roles in cardiovascular disease progression, prevention, and treatment.
    Cardiovasc Res. 2023;119:371-380.
    

    >> Share

    
    
13. WOOD A, Antonopoulos A, Chuaiphichai S, Kyriakou T, et al
    PHACTR1 modulates vascular compliance but not endothelial function: a translational study.
    Cardiovasc Res. 2023;119:599-610.
    

    >> Share

    
    
14. KLEINBONGARD P, Lieder H, Skyschally A, Heusch G, et al
    No sex-related differences in infarct size, no-reflow, and protection by ischaemic pre-conditioning in Gottingen minipigs.
    Cardiovasc Res. 2023;119:561-570.
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

15. HUANG C, Murugiah K, Li X, Masoudi FA, et al
    Effect of the New Glomerular Filtration Rate Estimation Equation on Risk Predicting Models for Acute Kidney Injury After Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2023 Apr 3:e012831.
    

    >> Share

    
    

    
    Circ Cardiovasc Qual Outcomes

16. LAWRENCE WR, Jones GS, Johnson JA, Ferrell KP, et al
    Discrimination Experiences and All-Cause and Cardiovascular Mortality: Multi-Ethnic Study of Atherosclerosis.
    Circ Cardiovasc Qual Outcomes. 2023 Apr 5:e009697.
    

    >> Share

    
    
17. HALL EJ, Ayers CR, Kolkailah AA, Rutan C, et al
    Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Circ Cardiovasc Qual Outcomes. 2023 Apr 5:e009652.
    

    >> Share

    
    

    
    Circ Res

18. HONEMANN JN, Gerlach D, Hoffmann F, Kramer T, et al
    Hypoxia and Cardiac Function in Patients With Prior Myocardial Infarction.
    Circ Res. 2023 Apr 3. doi: 10.1161/CIRCRESAHA.122.322334.
    

    >> Share

    
    
19. CANNAVO A, Jun S, Rengo G, Marzano F, et al
    beta3AR-Dependent BDNF (Brain-Derived Neurotrophic Factor) Generation Limits Chronic Postischemic Heart Failure.
    Circ Res. 2023 Mar 8. doi: 10.1161/CIRCRESAHA.122.321583.
    

    >> Share

    
    

    
    Circulation

20. AKL E, Sniderman AD
    Cholesterol, Coronary Calcification, and Cardiovascular Prevention: Lessons We Can Learn From the Western Denmark Heart Registry.
    Circulation. 2023;147:1064-1066.
    

    >> Share

    
    
21. PEREZ DE ISLA L, Diaz-Diaz JL, Romero MJ, Muniz-Grijalvo O, et al
    Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
    Circulation. 2023 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.062557.
    

    >> Share

    
    

    
    Clin Cardiol

22. WANG Y, Sun J, Sun K, Li L, et al
    ECG-based cardiodynamicsgram can reflect anomalous functional information in coronary artery disease.
    Clin Cardiol. 2023 Apr 6. doi: 10.1002/clc.24019.
    

    >> Share

    
    
23. VERVAAT FE, van der Gaag A, Smetsers C, Barneveld PC, et al
    Design and rationale of the efficacy of spinal cord stimulation in patients with refractory angina pectoris (SCRAP) trial.
    Clin Cardiol. 2023 Apr 4. doi: 10.1002/clc.24016.
    

    >> Share

    
    

    
    Clin Chem

24. FABRE-ESTREMERA B, Smith SW, Sandoval Y, Schulz K, et al
    Rapid Rule-Out of Myocardial Infarction Using a Single High-Sensitivity Cardiac Troponin I Measurement Strategy at Presentation to the Emergency Department: The SAFETY Study.
    Clin Chem. 2023 Apr 6:hvad033. doi: 10.1093.
    

    >> Share

    
    

    
    Curr Opin Cardiol

25. SALEH A, Al-Abcha A, Pereira N
    Pharmacogenetics of cardiovascular drugs.
    Curr Opin Cardiol. 2023;38:207-214.
    

    >> Share

    
    

    
    Eur Heart J

26. HIRANO KI, Higashi M, Nakajima K
    Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy.
    Eur Heart J. 2023;44:1191.
    

    >> Share

    
    

    
    J Am Coll Cardiol

27. BRANDT EJ, Tobb K, Cambron JC, Ferdinand K, et al
    Assessing and Addressing Social Determinants of Cardiovascular Health: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;81:1368-1385.
    

    >> Share

    
    
28. BELMONT JW
    Genetic Epidemiology Highlights the Role of Aortic Strain and Distensibility in Cardiovascular Disease.
    J Am Coll Cardiol. 2023;81:1336-1338.
    

    >> Share

    
    

    
    J Mol Cell Cardiol

29. LI R, Xiang C, Li Y, Nie Y, et al
    Targeting immunoregulation for cardiac regeneration.
    J Mol Cell Cardiol. 2023;177:1-8.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

30. URSO S, Sadaba R, Gonzalez Martin JM, Dayan V, et al
    Coronary surgery provides better survival than drug eluting stent: a pooled meta-analysis of Kaplan-Meier-derived individual patient data.
    J Thorac Cardiovasc Surg. 2023 Mar 29:S0022-5223(23)00258.
    

    >> Share

    
    

    
    JAMA

31. ROEHM E
    Medicare Advantage vs Traditional Medicare and 30-Day Mortality in Patients With AMI.
    JAMA. 2023;329:1121.
    

    >> Share

    
    
32. LANDON BE, Curto V, Ayanian JZ
    Medicare Advantage vs Traditional Medicare and 30-Day Mortality in Patients With AMI-Reply.
    JAMA. 2023;329:1121-1122.
    

    >> Share

    
    
33. LANDON BE, Hatfield LA, Bakx P, Banerjee A, et al
    Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries.
    JAMA. 2023;329:1088-1097.
    

    >> Share

    
    

    
    Mayo Clin Proc

34. RIZZO SA, Yalamuri SM, Rosenbaum AN, Anavekar NS, et al
    Percutaneous Mechanical Circulatory Support as a Bridge to Transplantation in Ebstein Anomaly.
    Mayo Clin Proc. 2023;98:626-630.
    

    >> Share

    
    
35. SUTHAHAR N, Wang D, Aboumsallem JP, Shi C, et al
    Association of Initial and Longitudinal Changes in C-reactive Protein With the Risk of Cardiovascular Disease, Cancer, and Mortality.
    Mayo Clin Proc. 2023;98:549-558.
    

    >> Share

    
    

    
    N Engl J Med

36. MESSERLI FH
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2023;388:1341-1342.
    

    >> Share

    
    
37. FRAVEL MA, Ernst ME
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.
    N Engl J Med. 2023;388:1342.
    

    >> Share

    
    
38. ISHANI A, Cushman WC, Leatherman SM
    Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. Reply.
    N Engl J Med. 2023;388:1342.
    

    >> Share

    
    

    
    PLoS Med

39. CHANG AY, Bryazka D, Dieleman JL
    Estimating health spending associated with chronic multimorbidity in 2018: An observational study among adults in the United States.
    PLoS Med. 2023;20:e1004205.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share